10 research outputs found
Survival of the posterior lamellar cornea graft keratocytes and endothelial cells cultivated in the modified corneal preservation media
Purpose. To study the survival of keratocytes and endothelial cells of a human donor cornea storage in the standard and the new media which was specifically designed for optim ized cornea hydration.Material and methods. 2D cell cultures of keratocytes and endothelial cells obtained from the Eye tissue bank were used for culture in improved storage media over a period of 14 and 7 days subsequently. To confirm phenotype characteristics, the cells were stained by the following markers: for keratocytes β Lumikan, Keratocan, and Ξ±-smooth muscle actin; for endothelial cells β ZO-1 and Na/K-ATPase. The onset of apoptosis in cell culture of keratocytes were detected with Cytochrome C, BAX, and Caspase 3 and 8. Viability of cell cultures after the cultivation was carried out using a commercial set of Β«Live and DeadΒ». Morphology of the endothelial cells was assessed using an electron scanning microscope.Results. It was shown that the 2D keratocyte culture cultured in the improved storage media expressed specific markers: Lumican, Keratocan, and did not express Ξ±-smooth muscle actin. There were no markers of apoptosis in the cell culture of keratocytes after 14 days of cultivation. Corneal endothelium cultured in the improved storage media expresses Β ZO-1, Na/K-ATPase and presented hexagonal cell shape morphology according to electron microscopy.Conclusion. The improved storage media allow to preserve the unique phenotype of keratocytes, with a slight decrease in proliferative cells activity during 14 days. The media maintain a viable and functional corneal endothelium for at least seven da ys of cultivation
PREOPERATIVE PREPARATION OF LIMBAL CELL TRANSPLANTS FOR THE TREATMENT OF OPTIC NEUROPATHY (EXPERIMENTAL STUDY)
Purpose. To study experimentally in vitro secretion of the nerve growth factor (NGF) and the brain-derived neurotrophic factor (BDNF) using intact and induced multi-potent mesenchymal limbal stem cells (MSCs) in three-dimensional culture (3D).Material and methods. MSCs were obtained by culturing of limbal fragments, isolated from the cadaveric human donor eyes, according to the medical technology of the S. Fyodorov Eye Microsurgery Federal State Institution. The phenotype of obtained cell culture was studied by the flow cytometry method.Stimulation of secretion of neurotrophic factors was performed via a two-step technique using non-specific activation factors: EGF, hbFGF, N2 additive, dibutyryl cAMP, NRG1-beta 1, PDGF, 3-isobutyl-1- methylxanthine. The 3D-cell spheroids were generated using agarose plates (3D Petri dishes, Microtissue, USA) for three comparative groups where: Group I β control, Group II β with the induction of spheroids at 1 day of cultivation; Group III β with induction of spheroids at 7 days of cultivation. The concentration of NGF and BDNF in the culture medium was studied using the enzyme linked immunosorbent assay (ELISA).Results. The induction of the 3D spheroids of limbal MSCs, that carried out on the 1st and 7th days of incubation, contributes to a significant increase in the production of NGF and BDNF, but subsequently a pronounced reduction in the secretion of these factors is observed. The conducting of an induction leads to a change in the morphology of spheroids: loss of compactness, the emergence of Β«fringedΒ» (debris). Such changes indicate a non-viability of the obtained 3D-cell spheroids.Conclusion. The cellular spheroids, created from 2D-culture of intact limbal MSCs by the three-dimensional culture method, are capable in sufficient therapeutic concentrations spontaneously to synthesize NGF and BDNF, have the most optimal design for transplantation in extrabulbar and intraocular tissue niches of the eyeball, are a potential source of prolonged secretion of neural basis function in cell treatment of optic neuropathy
Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠ΅Ρ Π½ΠΈΠΊΠΈ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΈ 3D-ΠΊΠ»Π΅ΡΠΎΠ½Π½ΡΡ ΡΡΠ΅ΡΠΎΠΈΠ΄ΠΎΠ² ΡΠ΅ΡΠΈΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΈΠ³ΠΌΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠ΅Π»ΠΈΡ Π² ΠΎΠΏΡΡΠ΅ Π½Π° ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
Aim. This research is aimed to devise the technique for transplantation of 3D spheroids retinal pigment epithelium (RPE) in the experimental animalβs eyes (rabbits).Materials and methods. 3D spheroids of RPE for subsequent transplantation were created using agarose tablets (3D Petri Dishes, Microtissue, USA). The phenotype of the obtained cell cultures was studied by immunocytochemical tests (laser scanning confocal microscope βFluo View FV10iβ, Olympus, Japan). Vitrectomy - 2500 cuts per minute, vacuum 600 mm Hg (Alcon, Accurus, USA) was performed on all rabbits (n = 10). Then, we made retinotomy and injected spheroids in subretinal space (MicroDose injection kit 1 ml, Med One, USA). The following methods of control: ultrasound B-scan (Ultrasonic UD-6000, Tomey, Japan) and optical coherence tomography (OCT), (Askin Spectralis, Heidelberg engineering, Germany). Eyes were enucleated for histological examination on 7, 10, 14 and 20 days.Results. Immunocytochemical tests revealed preservation of the RPE epithelial phenotype in 3D spheroids. Clinical map was similar in all experimental animals - during the first 7 days after surgery we saw cystic edema and flat retinal detachment in the surgery area. As we observed, the retina was adjoining and retinal edema was decreasing. Also, on day 3, 7 and 10 on OCT we saw subretinal round conglomerates with a diameter of 60 to 80 Β΅m - presumably RPE 3D spheroids. According to histological findings, there was observed adhesion of the RPE spheroids to the choroid with subsequent spreading and formation of new cell layer with the increase of observation periods.Conclusion. The proposed technology of cultivation of rabbit RPE with subsequent construction of 3D spheroids allows to preserve the epithelial phenotype of cells. The developed surgical technique of RPE transplantation is acceptable and can be used for further experimental studies to be implemented in clinical practice.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π Π°Π·ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠ΅Ρ
Π½ΠΈΠΊΠΈ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΈ SD-ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΡΡΠ΅ΡΠΎΠΈΠ΄ΠΎΠ² ΡΠ΅ΡΠΈΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΠΈΠ³ΠΌΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ ΡΠΏΠΈΡΠ΅Π»ΠΈΡ (Π ΠΠ) Π½Π° Π³Π»Π°Π·Π°Ρ
ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ
ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
(ΠΊΡΠΎΠ»ΠΈΠΊΠΈ).ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. SD-ΡΡΠ΅ΡΠΎΠΈΠ΄Ρ Π ΠΠ Π΄Π»Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΉ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΈ ΡΠΎΠ·Π΄Π°Π²Π°Π»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π°Π³Π°ΡΠΎΠ·Π½ΡΡ
ΠΏΠ»Π°Π½ΡΠ΅ΡΠΎΠ² (3D Petri Dishes, Microtissue, Π‘Π¨Π). Π€Π΅Π½ΠΎΡΠΈΠΏ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ
ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΠΊΡΠ»ΡΡΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΈΠΌΠΌΡΠ½ΠΎΡΠΈΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° (Π»Π°Π·Π΅ΡΠ½ΡΠΉ ΡΠΊΠ°Π½ΠΈΡΡΡΡΠΈΠΉ ΠΊΠΎΠ½ΡΠΎΠΊΠ°Π»ΡΠ½ΡΠΉ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏ Β«Fluo View FV10iΒ», Olympus, Π―ΠΏΠΎΠ½ΠΈΡ). ΠΡΠ΅ΠΌ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠΌ ΠΆΠΈΠ²ΠΎΡΠ½ΡΠΌ (ΠΊΡΠΎΠ»ΠΈΠΊΠΈ ΠΏΠΎΡΠΎΠ΄Ρ ΡΠΈΠ½ΡΠΈΠ»Π»Π°, n = 10) Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ Π²ΠΈΡΡΡΠΊΡΠΎΠΌΠΈΡ - 2500 ΡΠ΅Π·ΠΎΠ² Π² ΠΌΠΈΠ½ΡΡΡ, Π²Π°ΠΊΡΡΠΌ 600 ΠΌΠΌ ΡΡ. ΡΡ. (Alcon, Accurus, Π‘Π¨Π), ΡΠ΅ΡΠΈΠ½ΠΎΡΠΎΠΌΠΈΡ ΠΈ ΡΡΠ±ΡΠ΅ΡΠΈΠ½Π°Π»ΡΠ½ΠΎ Π²Π²ΠΎΠ΄ΠΈΠ»ΠΈ ΡΡΠ΅ΡΠΎΠΈΠ΄Ρ Π ΠΠ (MicroDose injection kit 1 ml, Med One, Π‘Π¨Π). ΠΠ΅ΡΠΎΠ΄Ρ ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ: ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠ΅ Π-ΡΠΊΠ°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π³Π»Π°Π·Π° (Ultrasonic UD-6000, Tomey, Π―ΠΏΠΎΠ½ΠΈΡ) ΠΈ ΠΎΠΏΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΊΠΎΠ³Π΅ΡΠ΅Π½ΡΠ½Π°Ρ ΡΠΎΠΌΠΎΠ³ΡΠ°ΡΠΈΡ - ΠΠΠ’ (Askin Spectralis, Heidelberg engineering, ΠΠ΅ΡΠΌΠ°Π½ΠΈΡ). ΠΠ»Π°Π·Π½ΡΠ΅ ΡΠ±Π»ΠΎΠΊΠΈ ΡΠ½ΡΠΊΠ»Π΅ΠΈΡΠΎΠ²Π°Π»ΠΈ Π½Π° 7, 10, 14, 20-Π΅ ΡΡΡΠΊΠΈ Π΄Π»Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅Π³ΠΎ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΌΠΌΡΠ½ΠΎΡΠΈΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΎΠΊΡΠ°ΡΠΈΠ²Π°Π½ΠΈΠ΅ Π²ΡΡΠ²ΠΈΠ»ΠΎ ΡΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΠ΅ ΡΠ΅Π½ΠΎΡΠΈΠΏΠ° Π ΠΠ Π² ΡΠΎΡΠΌΠ΅ 3D-ΡΡΠ΅-ΡΠΎΠΈΠ΄ΠΎΠ². Π ΠΏΠΎΡΠ»Π΅ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΎΠ½Π½ΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ Ρ Π²ΡΠ΅Ρ
ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ
ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΡΠ»ΡΡΡΠ°Π·Π²ΡΠΊΠΎΠ²ΠΎΠ³ΠΎ Π-ΡΠΊΠ°Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΈ ΠΠΠ’ ΠΎΡΠΌΠ΅ΡΠ°Π»Π°ΡΡ ΡΡ
ΠΎΠΆΠ°Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΊΠ°ΡΡΠΈΠ½Π°: ΠΎΡΠ΅ΠΊ ΠΈ ΠΏΠ»ΠΎΡΠΊΠ°Ρ ΠΎΡΡΠ»ΠΎΠΉΠΊΠ° ΡΠ΅ΡΡΠ°ΡΠΊΠΈ Π² Π·ΠΎΠ½Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ²Π°. ΠΠΎ ΠΌΠ΅ΡΠ΅ Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ ΡΠ΅ΡΡΠ°ΡΠΊΠ° ΠΏΡΠΈΠ»Π΅Π³Π°Π»Π° ΠΈ ΠΎΡΠ΅ΠΊ ΡΠ΅ΡΡΠ°ΡΠΊΠΈ ΡΠΌΠ΅Π½ΡΡΠ°Π»ΡΡ. Π’Π°ΠΊΠΆΠ΅, ΠΏΠΎ Π΄Π°Π½Π½ΡΠΌ ΠΠΠ’, ΡΡΠ±ΡΠ΅ΡΠΈΠ½Π°Π»ΡΠ½ΠΎ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°Π»ΠΈΡΡ ΠΎΠΊΡΡΠ³Π»ΡΠ΅ ΠΊΠΎΠ½Π³Π»ΠΎΠΌΠ΅ΡΠ°ΡΡ Π΄ΠΈΠ°ΠΌΠ΅ΡΡΠΎΠΌ ΠΎΡ 60 Π΄ΠΎ 80 ΠΌΠΊΠΌ - ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½ΠΎ 3D-ΡΡΠ΅ΡΠΎΠΈΠ΄Ρ Π ΠΠ. ΠΠΎ Π΄Π°Π½Π½ΡΠΌ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΎΡΠΌΠ΅ΡΠ°Π»Π°ΡΡ Π°Π΄Π³Π΅Π·ΠΈΡ ΡΡΠ΅ΡΠΎΠΈΠ΄ΠΎΠ² Π ΠΠ ΠΊ ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ ΠΎΠ±ΠΎΠ»ΠΎΡΠΊΠ΅ Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠΈΠΌ ΡΠ°ΡΠΏΠ»Π°ΡΡΡΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈ ΠΎΠ±ΡΠ°Π·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠ»ΠΎΡ ΠΏΠΎ ΠΌΠ΅ΡΠ΅ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΡΡΠΎΠΊΠΎΠ² Π½Π°Π±Π»ΡΠ΄Π΅Π½ΠΈΡ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠ΅Π΄Π»ΠΎΠΆΠ΅Π½Π½Π°Ρ ΡΠ΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΡ ΠΊΡΠ»ΡΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΠΊΡΠΎΠ»ΠΈΡΡΠ΅Π³ΠΎ Π ΠΠ Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠΈΠΌ ΠΊΠΎΠ½ΡΡΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ 3D-ΡΡΠ΅ΡΠΎΠΈΠ΄ΠΎΠ² ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΡΠΎΡ
ΡΠ°Π½ΠΈΡΡ ΡΠΏΠΈΡΠ΅Π»ΠΈΠ°Π»ΡΠ½ΡΠΉ ΡΠ΅Π½ΠΎΡΠΈΠΏ ΠΊΠ»Π΅ΡΠΎΠΊ. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½Π°Ρ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ΅Ρ
Π½ΠΈΠΊΠ° ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΈ Π ΠΠ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΏΡΠΈΠ΅ΠΌΠ»Π΅ΠΌΠΎΠΉ ΠΈ ΠΌΠΎΠΆΠ΅Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°ΡΡΡΡ Π΄Π»Ρ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΡ
ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΡ
ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΉ Ρ ΡΠ΅Π»ΡΡ Π²Π½Π΅Π΄ΡΠ΅Π½ΠΈΡ Π² ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΡΡ ΠΏΡΠ°ΠΊΡΠΈΠΊΡ
Neurotrophic factors and cell therapy in the treatment of glaucomatous optic neuropathy
At present it is accepted that glaucoma is a multi-factorial neurodegenerative disease, in which process there occur a death of retinal ganglion cells (RGC), progressive optic neuropathy and a visual field loss.In recent years, a number of large multicenter studies have convincingly shown that the effective reduction of intraocular pressure by medication and surgical methods does not guarantee a long-term stabilization of the glaucomatous process, andΒ therefore a number of patients have a progression of the neurodegenerative process.This fact determines the necessity to search new ways of glaucoma optic neuropathy therapy, one of these can be the neuroprotection based on the methods of cell therapy.It is shown that the apoptosis is the primary mechanism of RGS death in glaucoma as in other neurodegenerative diseases. Currently found a large number of triggers of RGS apoptosis. One of the most important is the factor blocking axoplasmatic transport of neurotrophins.Neurotrophins are a family of structurally and functionally similar polypeptides that plays an important role in the differentiation, survival and regeneration of neurons.Numerous studies have shown that the neurotrophic factors in general, especially brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) significantly improves the RGC survival in experimental models of glaucoma.It is revealed that multipotent mesenchymal stromal cells (MMSC) can release a large number of bioactive factors, including neurotrophins, both in vivo, as well as in experiments in vitro.MMSC of eye limbus phenotypic match the bone marrowderived mesenchymal stromal cells. During MMSC culturing they secrete a wide variety of cytokines, interleukins, growth-factors. Therefore we consider the transplantation of allogenic limbus fragments as a candidate for cell therapy in the treatment of glaucomatous optic neuropathy
Screening of cadaver cornea donor for infections in the eye bank of the Fyodorov Eye Microsurgery Federal State Institution
Objective: to analyze negative laboratory results of cadaver cornea donor screening during preparation of corneas for transplantation according to data from the internal registry of donors of the eye bank (EB) of the Fyodorov Eye Microsurgery Federal State Institution and the European Eye Bank Association (EEBA) from 2011 through 2015. Materials and methods. Data analysis was carried out using the internal registry of EB donors and the EEBA annual directories. The analyzed data included the number of eyeballs obtained, the frequency of incomplete tests (hemolysis for EB) and positive serological results for human immunodeficiency virus (HIV-1 and HIV-2), viral hepatitis B, viral hepatitis C and syphilis. Results. In just 5 years, the EB received 3,479 eyeballs. After hemolysis of donor blood samples, 13.9% (n = 486) of corneas were excluded from the EB. EEBA recorded fewer inconclusive tests during the same period. After hemolysis and positive serological tests, 19.4% (n = 676) of corneas were excluded from the EB. Overall, the number of positive serological tests in EBs was far higher than in the EEBA data. Frequency of positive HIV tests (HIV-1 and HIV-2) and syphilis in EB showed low variability annually, while incidence of hepatitis B increased in 2015. For the analyzed period, positive serology for hepatitis C was found to be prevalent among EB donors. Mixed infections were quite often recorded in blood samples. Conclusion. Based on analysis conducted, positive serology and hemolysis were the main contraindications and led to exclusion of 33.3% (n = 1162) of cadaver donor corneas received in EB. Frequency of positive serological tests for indicated infections in EB was higher than in the EEBA data, with significant predomination of hepatitis C
Development optimal conditions for cryopreservation of tissue-engineered corneal constructs
Relevance. In recent years, due to the shortage of donor corneas, the need to creating conditions for storing stromal lenticules in eye banks for their clinical use in ophthalmosurgery have been actively discussed. Currently, scientists are looking for optimal conditions for storage native lenticules. There were no reports of storage of decellularized lenticules in the literature.Β Purpose. To develop optimal conditions for cryopreservation of stromal tissue-engineered constructs for the subsequent creation of a cryobank.Β Material and methods. The optical properties of native lenticules and tissueβengineered corneal constructs (TCs) were assessed using spectrophotometry. We used a decellularization protocol with 1.5 M NaCl with DNase 5 U/ml and RNase 5 U/ml to create TC. Dispersed viscoelastic agent approved for clinical use in ophthalmology was used for dehydration of TC. Three comparison groups were formed: 1st β control group (native lenticules), 2nd β group without dehydration of TC, 3rd β group with dehydration of TC. The spectrophotometer data was evaluated in 2 stages. The transparency of the control group was measured at 1 stage. At the second stage, the transparency of two experimental groups after storage in DMSO was investigated (a group without dehydration of TC and a group with dehydration of TC).Β Results. When compared between groups without dehydration of TC; with dehydration of TC and the control group (pβ₯0.05), no statistical difference was revealed, and when comparing groups without dehydration of TC and groups with dehydration of TC (pβ₯0.05), no statistical difference was revealed.Β Conclusion. Groups with dehydration of TC and without dehydration of TC after storage in DMSO did not differ in transparency. In this regard, these groups should be considered as interchangeable in terms of optical properties
The development of transplantation technique of 3D spheroids retinal pigment epithelium in the experiment on animals
Aim. This research is aimed to devise the technique for transplantation of 3D spheroids retinal pigment epithelium (RPE) in the experimental animalβs eyes (rabbits).Materials and methods. 3D spheroids of RPE for subsequent transplantation were created using agarose tablets (3D Petri Dishes, Microtissue, USA). The phenotype of the obtained cell cultures was studied by immunocytochemical tests (laser scanning confocal microscope βFluo View FV10iβ, Olympus, Japan). Vitrectomy - 2500 cuts per minute, vacuum 600 mm Hg (Alcon, Accurus, USA) was performed on all rabbits (n = 10). Then, we made retinotomy and injected spheroids in subretinal space (MicroDose injection kit 1 ml, Med One, USA). The following methods of control: ultrasound B-scan (Ultrasonic UD-6000, Tomey, Japan) and optical coherence tomography (OCT), (Askin Spectralis, Heidelberg engineering, Germany). Eyes were enucleated for histological examination on 7, 10, 14 and 20 days.Results. Immunocytochemical tests revealed preservation of the RPE epithelial phenotype in 3D spheroids. Clinical map was similar in all experimental animals - during the first 7 days after surgery we saw cystic edema and flat retinal detachment in the surgery area. As we observed, the retina was adjoining and retinal edema was decreasing. Also, on day 3, 7 and 10 on OCT we saw subretinal round conglomerates with a diameter of 60 to 80 Β΅m - presumably RPE 3D spheroids. According to histological findings, there was observed adhesion of the RPE spheroids to the choroid with subsequent spreading and formation of new cell layer with the increase of observation periods.Conclusion. The proposed technology of cultivation of rabbit RPE with subsequent construction of 3D spheroids allows to preserve the epithelial phenotype of cells. The developed surgical technique of RPE transplantation is acceptable and can be used for further experimental studies to be implemented in clinical practice
The first experience of 3D spheroids retinal pigment epithelium transplantation in the experiment
Introduction. Available methods in the treatment of age-related macular degeneration (AMD) do not always lead to significant vision improvement.A new advanced method of AMD treatment is transplantation of retinal pigment epithelium (RPE) in the form of cell suspension or choroidal pigment complex.In our opinion, the most modern form of RPE transplant is a multicellular spheroid - the form of 3D cell culture in which cells are close to the conditions of native tissue.However, transplantation of 3D spheroids of RPE requires preclinical studies.Purpose. This research is aimed to devise the technique for transplantation of RPE 3D spheroids in the eyes of experimental animals (rabbits).Material and methods. 1. In vitro research phase. For immunocytochemical tests the 3D spheroids were explored on the 3rd, 7th, and 11th day of steroidogenesis (using the laser scanning confocal microscope Β«Fluo View FV10iΒ», Olympus, Japan). The expression of epithelial markers (Alexa Fluor, Great Britain), such as: RPE65, ZO-1, Cytokeratin 8, 18, and Vimentin (the mesenchymal marker) was analyzed.2. In vivo research phase. Vitrectomy (2500 cuts per minute, vacuum 600 mmHg), (Alcon, Accurus, USA) was performed on all rabbits (n=10). Then, a sharp cannula 39G was used to make a retinotomy above the central zone of retina, and spheroids (n=81) were injected (MicroDose injection kit 1 ml, Med One, USA) in subretinal space. The operation ended with the replacement of fluid into air and suturing scleral incision and the conjunctiva. The following methods of control were used: ultrasound B-scan (Ultrasonic UD-6000, Tomey, Japan) and optical coherence tomography (OCT) - (Askin Spectralis, Heidelberg engineering, Germany).Animals were taken out of the experiment on days 7, 10, 14 and 20 by air embolism. The eyeballs were enucleated for a subsequent histological examination.Results. 1. In vitro research phase. During immunocytochemical tests on the obtained 3D cultures, the presence of high expression of specific marker of retinal pigment epithelium RPE-65, also epithelial markers Cytokeratin 8, 18 and ZO-1 was noted. The expression of mesenchymal marker Vimentin was weak - that indicates the advantage of 3D cultivation of RPE cells to keep their phenotype. This indicates the advantage of 3D cultivation of epithelial cells to preserve their epithelial phenotype.2. In vivo research phase. On day 1 during ultrasonic B-scanning in 6 rabbits there was observed a flat retinal detachment in the area of surgical intervention height up to 1 mm; in 4 rabbits there was detected adhesion of the membranes, detachment of retina was not visible.The picture of the morphological state during retinal OCT was similar in all experimental animals - during the first 7 days after surgery cystic edema was noted and also a flat retinal detachment in the surgery area. As we observed, the retina was attaching and retinal edema was decreasing. Also, on day 3, 7 and 10 we revealed subretinal round conglomerates with a diameter of 60 to 80 pm - presumably RPE 3D spheroids. No morphological changes of the retina were seen on day 14 and day 20.According to histological findings, there was found adhesion of the RPE spheroids to the choroid with subsequent spreading and formation of a new cell layer with an increase of follow-up periods.Conclusion. 1. The proposed technology of cultivation of rabbit RPE with subsequent construction of 3D spheroids allows to preserve the epithelial phenotype of cells, that is confirmed by immunocytochemical tests.2. The developed surgical technique of RPE transplantation is acceptable, that is confirmed by the OCT and histological investigation.3. The proposed surgical technique of subretinal transplantation of 3D spheroids of RPE is promising for further experimental studies to be implemented in clinical practice
Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΡΠΎΡΠΎΠΊΠΎΠ»ΠΎΠ² Π΄Π΅ΡΠ΅Π»Π»ΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΠΈ Π»Π΅Π½ΡΠΈΠΊΡΠ»ΡΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΡΠΎΠ³ΠΎΠ²ΠΈΡΡ
Shortage of donor corneas is a burning issue in ophthalmology. That is why there is a search for new alternative ways for treating corneal diseases. Decellularization technologies make it possible to create corneal tissue-engineered constructs that can adrress the issue of donor corneal shortage. Objective: to conduct a comparative analysis of effective methods for treating the corneal lenticula and to create an optimized and standardized decellularization protocol. Materials and methods. Corneal stromal lenticules obtained after ReLEx SMILE surgery were chosen for the study. Lenticule parameters: thickness 77β120 microns, diameter 6.5 mm. We used 3 protocols for the treatment of lenticules: 1) treatment with 1.5 M sodium chloride with nucleases (NaCl); 2) 0.1% SDS (SDS); 3) treatment with Trypsin-EDTA solution, followed by double washing in a hypotonic Tris buffer solution with nucleases (Trypsin-EDTA). Optical properties of lenticles were determined spectrophotometrically, where the samples before decellularization served as a control. Fluorescence imaging of nuclear material in the original cryosections was performed using Hoechst dye. The state of collagen fiber ultrastructure was assessed by scanning electron microscopy. The quantitative DNA content in fresh lenticules and in lenticules after treatment was analyzed. Results. All three decellularization protocols effectively removed nuclear and cellular material; the residual DNA content was < 50 ng/mg. However, the Trypsin-EDTA protocol led to significant damage to the extracellular matrix structure, which negatively affected the transparency of corneal tissue-engineered constructs. Transparency of samples for the NaCl protocol was close to native lenticules. Conclusion. To create a corneal tissue-engineered construct, NaCl decellularization protocols appear to be optimized and can be used to treat various corneal diseases.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΎΠΉ ΠΎΡΡΠ°Π»ΡΠΌΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠ²Π»ΡΠ΅ΡΡΡ Π΄Π΅ΡΠΈΡΠΈΡ Π΄ΠΎΠ½ΠΎΡΡΠΊΠΈΡ
ΡΠΎΠ³ΠΎΠ²ΠΈΡ. ΠΠ°Π½Π½ΡΠΉ ΡΠ°ΠΊΡ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»ΠΈΠ²Π°Π΅Ρ ΠΏΠΎΠΈΡΠΊ Π½ΠΎΠ²ΡΡ
Π°Π»ΡΡΠ΅ΡΠ½Π°ΡΠΈΠ²Π½ΡΡ
ΠΏΡΡΠ΅ΠΉ Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΉ ΡΠΎΠ³ΠΎΠ²ΠΈΡΡ. Π’Π΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ Π΄Π΅ΡΠ΅Π»Π»ΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΡΡ ΡΠΎΠ·Π΄Π°Π²Π°ΡΡ ΡΠΎΠ³ΠΎΠ²ΠΈΡΠ½ΡΠ΅ ΡΠΊΠ°Π½Π΅ΠΈΠ½ΠΆΠ΅Π½Π΅ΡΠ½ΡΠ΅ ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΌΠΎΠ³ΡΡ ΡΠ΅ΡΠΈΡΡ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ Π½Π΅Ρ
Π²Π°ΡΠΊΠΈ Π΄ΠΎΠ½ΠΎΡΡΠΊΠΈΡ
ΡΠΎΠ³ΠΎΠ²ΠΈΡ.Π¦Π΅Π»Ρ. ΠΡΠΎΠ²Π΅ΡΡΠΈ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ ΡΠΎΠ³ΠΎΠ²ΠΈΡΠ½ΠΎΠΉ Π»Π΅Π½ΡΠΈΠΊΡΠ»Ρ ΠΈ ΡΠΎΠ·Π΄Π°ΡΡ ΠΎΠΏΡΠΈΠΌΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΠΈ ΡΡΠ°Π½Π΄Π°ΡΡΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΠΏΡΠΎΡΠΎΠΊΠΎΠ» Π΄Π΅ΡΠ΅Π»Π»ΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ»ΠΈ Π²ΡΠ±ΡΠ°Π½Ρ ΡΡΡΠΎΠΌΠ°Π»ΡΠ½ΡΠ΅ ΡΠΎΠ³ΠΎΠ²ΠΈΡΠ½ΡΠ΅ Π»Π΅Π½ΡΠΈΠΊΡΠ»Ρ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΠΏΠΎΡΠ»Π΅ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ ReLEx SMILE. ΠΠ°ΡΠ°ΠΌΠ΅ΡΡΡ Π»Π΅Π½ΡΠΈΠΊΡΠ»: ΡΠΎΠ»ΡΠΈΠ½Π° 77β120 ΠΌΠΊΠΌ, Π΄ΠΈΠ°ΠΌΠ΅ΡΡ 6,5 ΠΌΠΌ. ΠΠ»Ρ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ Π»Π΅Π½ΡΠΈΠΊΡΠ»Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ 3 ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Π°: 1) ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° 1,5 Π Ρ
Π»ΠΎΡΠΈΠ΄ΠΎΠΌ Π½Π°ΡΡΠΈΡ Ρ Π½ΡΠΊΠ»Π΅Π°Π·Π°ΠΌΠΈ (NaCl); 2) 0,1% SDS (SDS); 3) ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΡΠ°ΡΡΠ²ΠΎΡΠΎΠΌ Π’ΡΠΈΠΏΡΠΈΠ½-ΠΠΠ’Π Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΌ Π΄Π²ΠΎΠΉΠ½ΡΠΌ ΠΎΡΠΌΡΠ²Π°Π½ΠΈΠ΅ΠΌ Π² Π³ΠΈΠΏΠΎΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΡΠΈΡ-Π±ΡΡΠ΅ΡΠ½ΠΎΠΌ ΡΠ°ΡΡΠ²ΠΎΡΠ΅ Ρ Π½ΡΠΊΠ»Π΅Π°Π·Π°ΠΌΠΈ (Π’ΡΠΈΠΏΡΠΈΠ½-ΠΠΠ’Π). ΠΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° Π»Π΅Π½ΡΠΈΠΊΡΠ» ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΡΠΏΠ΅ΠΊΡΡΠΎΡΠΎΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈ, Π³Π΄Π΅ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΡΠ»ΡΠΆΠΈΠ»ΠΈ ΠΎΠ±ΡΠ°Π·ΡΡ Π΄ΠΎ Π΄Π΅ΡΠ΅Π»Π»ΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΠΈ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΡΡΡΠΊΡΡΡΡ ΡΡΡΠΎΠΌΡ ΡΠΎΠ³ΠΎΠ²ΠΈΡΠ½ΠΎΠΉ Π»Π΅Π½ΡΠΈΠΊΡΠ»Ρ ΠΏΠΎΡΠ»Π΅ Π΄Π΅ΡΠ΅Π»Π»ΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΠΈ ΠΏΡΠΎΠΈΡΡ
ΠΎΠ΄ΠΈΠ»ΠΎ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΎΠΊΡΠ°ΡΠΈΠ²Π°Π½ΠΈΡ Π³Π΅ΠΌΠ°ΡΠΎΠΊΡΠΈΠ»ΠΈΠ½ΠΎΠΌ ΠΈ ΡΠΎΠ·ΠΈΠ½ΠΎΠΌ, ΠΏΠΎ ΠΠ°Π½-ΠΠΈΠ·ΠΎΠ½Ρ ΠΈ Π°Π»ΡΡΠΈΠ°Π½ΠΎΠ²ΡΠΌ ΡΠΈΠ½ΠΈΠΌ. Π’Π°ΠΊΠΆΠ΅ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΎΡΠ΅Π½ΠΊΠΈ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ Π²Π½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΡΠΈΠΊΡΠ°, Π° ΠΈΠΌΠ΅Π½Π½ΠΎ ΠΊΠΎΠ»Π»Π°Π³Π΅Π½Π° I, III, V ΠΈ VI ΡΠΈΠΏΠΎΠ², ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ³ΠΈΡΡΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΊΡΠΈΠΎΡΡΠ΅Π·ΠΎΠ² Π½Π°ΡΠΈΠ²Π½ΡΡ
ΠΎΠ±ΡΠ°Π±ΠΎΡΠ°Π½Π½ΡΡ
Π»Π΅Π½ΡΠΈΠΊΡΠ». Π€Π»ΡΠΎΡΠ΅ΡΡΠ΅Π½ΡΠ½Π°Ρ Π²ΠΈΠ·ΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡ ΡΠ΄Π΅ΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΠ΅ΡΠΈΠ»Π° Π² ΠΈΡΡ
ΠΎΠ΄Π½ΡΡ
ΠΊΡΠΈΠΎΡΡΠ΅Π·Π°Ρ
ΠΏΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠ»Π°ΡΡ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΊΡΠ°ΡΠΈΡΠ΅Π»Ρ Hoechst. Π‘ΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΡΠ»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΡ ΠΊΠΎΠ»Π»Π°Π³Π΅Π½ΠΎΠ²ΡΡ
Π²ΠΎΠ»ΠΎΠΊΠΎΠ½ ΠΎΡΠ΅Π½ΠΈΠ²Π°Π»ΠΎΡΡ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠΊΠ°Π½ΠΈΡΡΡΡΠ΅Π³ΠΎ ΡΠ»Π΅ΠΊΡΡΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΌΠΈΠΊΡΠΎΡΠΊΠΎΠΏΠΈΡΠΎΠ²Π°Π½ΠΈΡ. ΠΡΠΎΠΈΠ·Π²ΠΎΠ΄ΠΈΠ»ΠΈ Π°Π½Π°Π»ΠΈΠ· ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΠΠΠ Π² ΡΠ²Π΅ΠΆΠΈΡ
Π»Π΅Π½ΡΠΈΠΊΡΠ»Π°Ρ
ΠΈ Π² Π»Π΅Π½ΡΠΈΠΊΡΠ»Π°Ρ
ΠΏΠΎΡΠ»Π΅ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠΈ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠ΅ ΡΡΠΈ ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Π° Π΄Π΅ΡΠ΅Π»Π»ΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ ΡΠ΄Π°Π»ΡΡΡ ΡΠ΄Π΅ΡΠ½ΡΠΉ ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΠΌΠ°ΡΠ΅ΡΠΈΠ°Π», ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΠΠ Π±ΡΠ»ΠΎ < 50 Π½Π³/ΠΌΠ³. ΠΠ΄Π½Π°ΠΊΠΎ ΠΏΡΠΎΡΠΎΠΊΠΎΠ» Ρ Π’ΡΠΈΠΏΡΠΈΠ½-ΠΠΠ’Π ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌΡ ΠΏΠΎΠ²ΡΠ΅ΠΆΠ΄Π΅Π½ΠΈΡ ΡΡΡΡΠΊΡΡΡΡ Π²Π½Π΅ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΌΠ°ΡΡΠΈΠΊΡΠ°, ΡΡΠΎ ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½ΠΎ ΡΠΊΠ°Π·ΡΠ²Π°Π΅ΡΡΡ Π½Π° ΠΏΡΠΎΠ·ΡΠ°ΡΠ½ΠΎΡΡΠΈ ΡΠΎΠ³ΠΎΠ²ΠΈΡΠ½ΡΡ
ΡΠΊΠ°Π½Π΅ΠΈΠ½ΠΆΠ΅Π½Π΅ΡΠ½ΡΡ
ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΉ. ΠΡΠΎΠ·ΡΠ°ΡΠ½ΠΎΡΡΡ ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² Π΄Π»Ρ ΠΏΡΠΎΡΠΎΠΊΠΎΠ»Π° NaCl Π±ΡΠ»Π° ΠΏΡΠΈΠ±Π»ΠΈΠΆΠ΅Π½Π° ΠΊ Π½Π°ΡΠΈΠ²Π½ΡΠΌ Π»Π΅Π½ΡΠΈΠΊΡΠ»Π°ΠΌ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ»Ρ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ ΡΠΎΠ³ΠΎΠ²ΠΈΡΠ½ΠΎΠΉ ΡΠΊΠ°Π½Π΅ΠΈΠ½ΠΆΠ΅Π½Π΅ΡΠ½ΠΎΠΉ ΠΊΠΎΠ½ΡΡΡΡΠΊΡΠΈΠΈ ΠΏΡΠΎΡΠΎΠΊΠΎΠ» Π΄Π΅ΡΠ΅Π»Π»ΡΠ»ΡΡΠΈΠ·Π°ΡΠΈΠΈ NaCl ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ ΠΎΠΏΡΠΈΠΌΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ ΠΈ ΠΌΠΎΠΆΠ΅Ρ ΠΏΡΠΈΠΌΠ΅Π½ΡΡΡΡΡ Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΉ ΡΠΎΠ³ΠΎΠ²ΠΈΡΡ